|
|
Detailed molecular and structural characterization of the meninges: an approach combining proteomics and Imaging Mass Cytometry |
| 1R21NS122369-01A1 |
|
NINDS |
2022 |
|
|
Non invasive in vivo imaging of pathological fibrin deposition in the human brain |
| 1R21NS126737-01 |
|
NINDS |
2022 |
|
|
Determinants of Alzheimers Disease in Atrial Fibrillation apart from Stroke: The NOMINATE Study |
| 1R21NS126967-01 |
|
NINDS |
2022 |
|
|
Neuroinflammation in Cerebral Small Vessel Disease using PET/MR Imaging |
| 1R21NS127425-01 |
|
NINDS |
2022 |
|
|
Synaptic vesicle changes in synucleinopathies |
| 1R21NS127939-01 |
|
NINDS |
2022 |
|
|
Acute Ischemic Tissue Evolution and Implications for Imaging Selection of Patients for Therapy and Clinical Trials using Sex-Disaggregated Data |
| 1R21NS130494-01 |
|
NINDS |
2022 |
|
|
Investigating how the microbiota modulates neuroinflammatory signaling and neurodegeneration in Parkinsons disease and dementia |
| 1R21NS130500-01 |
|
NINDS |
2022 |
|
|
Validation of HYPE as an Actionable Target for Alzheimers Disease |
| 1RF1NS124779-01A1 |
|
NINDS |
2022 |
|
|
Validation of HYPE as an Actionable Target for Alzheimers Disease |
| 1RF1NS124779-01A1 |
|
NINDS |
2022 |
|
|
α-Synuclein strain properties are associated with diagnosis of and progression to Parkinsons disease with dementia |
| 1RF1NS125592-01 |
|
NINDS |
2022 |